Orenitram and Terminal state - a phase IV clinical study of FDA data

Summary:

Terminal state is reported as a side effect among people who take Orenitram (treprostinil), especially for people who are female, 60+ old, also take Ambrisentan, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Terminal state when taking Orenitram. It is created by eHealthMe based on reports of 17,713 people who have side effects when taking Orenitram from the FDA, and is updated regularly.

What is Orenitram?

Orenitram has active ingredients of treprostinil. eHealthMe is studying from 17,714 Orenitram users. Check the latest studies of Orenitram.

What is Terminal state?

Terminal state (the transitional states between life and biological death) is found to be associated with 374 drugs and 559 conditions by eHealthMe. Check the latest studies of Terminal state.

On Jul, 14, 2026

17,713 people reported to have side effects when taking Orenitram.
Among them, 12 people (0.07%) have Terminal state.

Among these 12 people:

What is the gender of people who have Terminal state when taking Orenitram? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Terminal state when taking Orenitram? *

What are other drugs people take besides Orenitram? *

What are other side effects people have besides Terminal state? *

Acute Kidney Failure: 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 16.67%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 16.67%
Fatigue (feeling of tiredness): 2 people, 16.67%
Death: 2 people, 16.67%
Chest Pain: 1 person, 8.33%
Constipation: 1 person, 8.33%
Cough: 1 person, 8.33%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 66.67%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Orenitram and have Terminal state?

- Check whether Terminal state is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Orenitram:

Orenitram (17,714 reports)

Terminal state treatments and more:

Terminal state (7,004 reports)

Browse all side effects of Orenitram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Terminal state:

Terminal state (374 drugs)

Browse all the conditions that are associated with Terminal state:

Terminal state (559 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on treprostinil (the active ingredients of Orenitram) and Orenitram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.